NAD+ is nicotinamide adenine dinucleotide, a molecule cells use in redox reactions and as a substrate for enzymes including PARPs and sirtuins. NADH is its reduced form, while NMN and NR are precursors used in NAD synthesis. Their biological importance does not by itself prove that a supplement or injection produces a health benefit.
Key takeaways
- NAD+ participates in cellular metabolism and enzyme reactions.
- NAD+ and NADH are different forms of the same redox pair.
- NMN and NR are precursors, not alternative names for NAD+.
- Human biomarker changes and human health outcomes are different evidence questions.
- Research on one molecule or administration route cannot automatically be applied to another.
What does NAD stand for?
NAD stands for nicotinamide adenine dinucleotide. The plus sign identifies the oxidized form; NADH is the reduced form. Cells interconvert NAD+ and NADH when transferring electrons in metabolic reactions.[1]
NAD+ also serves as a substrate for NAD-consuming enzymes, including poly(ADP-ribose) polymerases and sirtuins. A biochemical role, however, is not evidence that taking extra NAD+ improves a particular outcome.[1]
NAD+, NMN and NR are not interchangeable
| Term | Plain-English description | What not to assume |
|---|---|---|
| NAD+ | The oxidized form of nicotinamide adenine dinucleotide | That a blood measurement predicts how a person will feel |
| NADH | The reduced partner in the NAD+/NADH redox pair | That NADH and NAD+ studies are interchangeable |
| NMN | Nicotinamide mononucleotide, an NAD precursor | That oral NMN evidence proves an effect from injected NAD+ |
| NR | Nicotinamide riboside, another NAD precursor | That NR and NMN have identical evidence |
Human trials have shown that oral NR and oral NMN can increase NAD-related measures in blood in the populations and study periods examined.[2][3] These findings do not establish the same pharmacology for a subcutaneous NAD+ pen and do not demonstrate anti-ageing or disease-treatment outcomes.
Does NAD decline with age?
A small human tissue study reported an association between age and lower NAD+ in pelvic skin samples.[1] That is useful human evidence, but it is tissue-specific and observational. It does not establish a universal rate of decline across organs, diagnose an individual deficiency or show that supplementation reverses ageing.
What does human research show?
The answer depends on the intervention and endpoint. A randomized crossover trial found increased NAD+ in peripheral blood mononuclear cells after oral NR; several physiological findings were exploratory.[2] A 60-day NMN trial reported increased blood NAD concentrations and changes in some secondary outcomes, with limits in population, duration and analysis.[3] A small IV pilot mapped metabolites; it was not a wellness efficacy trial.[4]
Evidence boundary: direct human evidence for subcutaneous NAD+ must be assessed separately rather than inferred from these studies.
Questions to ask before choosing a product
- Which molecule and administration route does it use?
- Does the cited research examine that same molecule and route?
- Does the study measure a biomarker, symptom or clinical outcome?
- Are the participants and duration relevant to the claim?
- Can the seller provide product-specific quality and safety documents?
Continue learning
Read our NAD pen beginner’s guide or compare pens, IV, oral NAD+, NMN and NR.
Sources: [1] Massudi et al., PLOS ONE 2012 · [2] Martens et al., Nature Communications 2018 · [3] Yi et al., GeroScience 2023 · [4] Grant et al., Frontiers in Aging Neuroscience 2019. This is a short scientific orientation, not a systematic review.